Sal Saudi Logistics Services Co. logo

Sal Saudi Logistics Services Co. (4263)

Market Closed
10 Aug, 12:00
XSAU XSAU
173. 00
+3
+1.7647%
- Market Cap
- P/E Ratio
- Div Yield
178,454 Volume
- Eps
170
Previous Close
Add Transaction
Day Range
168.1 173.7
Year Range
148.2 186
Want to track 4263 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4263 closed today higher at ﷼173, an increase of 1.7647% from yesterday's close, completing a monthly decrease of -3.8355% or -﷼6.9. Over the past 12 months, 4263 stock gained 7.9226%.
4263 pays dividends to its shareholders, with the most recent payment made on Jun 11, 2026. The next announced payment will be in In 1 weeks on Aug 20, 2026 for a total of ﷼1.79.
The last earnings report, released on May 11, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 1.594%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on JPX (JPY).

4263 Chart

Sal Saudi Logistics Services Co. (4263) FAQ

What is the stock price today?

The current price is ﷼173.00.

On which exchange is it traded?

Sal Saudi Logistics Services Co. is listed on XSAU.

What is its stock symbol?

The ticker symbol is 4263.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Sal Saudi Logistics Services Co. ever had a stock split?

No, there has never been a stock split.

Sal Saudi Logistics Services Co. Profile

Insurance Industry
Financials Sector
Mr. Taro Ueno CEO
XSAU Exchange
SA15T1L22JH8 ISIN
Japan Country
43 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

SUSMED, Inc., established in 2015 and headquartered in Tokyo, Japan, stands at the forefront of the digital therapeutics landscape. The company is dedicated to developing and commercializing innovative therapeutic applications, focusing on enriching patient care through the integration of technology. By harnessing the potential of smartphone-based digital applications, SUSMED aims to address the challenges presented by a variety of diseases, including insomnia, breast cancer, and kidney disease. Alongside its product development efforts, SUSMED extends its expertise to provide medical data analysis and consulting services, driven by a mission to enhance the efficacy of health care solutions through digital innovation.

Products and Services

  • Smartphone Based Digital Therapeutics Applications

    SUSMED leverages mobile technology to create accessible, user-friendly digital therapies. These applications target a range of conditions, such as insomnia, breast cancer, and kidney disease, providing patients with innovative treatment options that complement traditional medical care. Through the convenience of smartphones, SUSMED's applications aim to facilitate improved health outcomes and enhance the quality of life for individuals facing these health challenges.

  • Development Platform for Therapeutic Apps and Clinical Trial Systems

    The company has developed a versatile platform designed to support the creation of therapeutic applications and the management of clinical trials. This platform is a testament to SUSMED's commitment to advancing digital therapeutics by providing a robust foundation for both development and research. By offering these technical resources, SUSMED empowers researchers and developers to explore new frontiers in medical treatment and healthcare optimization.

  • Medical Data Analysis and Consulting Services

    Understanding the critical role of data in healthcare, SUSMED provides comprehensive analysis and consulting services. These services are tailored to assist clients in navigating the complexities of medical data, facilitating informed decision-making and innovative healthcare solutions. With an emphasis on leveraging data for enhanced treatment strategies, SUSMED positions itself as a key player in the movement towards data-driven healthcare.

Contact Information

Address: MFPR Nihonbashi honcho Bldg
Phone: 86 3 6366 7780